|
Our
Products
| |
|
Astounding Results from
Africa Study. . . |
Re-Vita's
Liqua Health
has been PROVEN
to strengthen the immune system and alleviate malnutrition and anemia. As
you can well imagine, we are so proud of our product and the things it can
do for your body. Below are the final conclusions of a year-long study done
in Kenya, Africa. The collaborating organizations of the study were Kenya
Medical Research Institute (KEMRI), Ministry of Health - Kenya, Department
of Defense - Kenya, and Re-Vita Manufacturing Co.
The objective of the study was to determine the effects of Re-Vita's
Liqua Health on nutrition and health of vulnerable 6 to 5 year-olds. The
number of study subjects reporting for medical treatment due to illnesses
was practically halved within two-months into the study. Focus group
discussions and key informant interviews with parents indicated reduction in
the frequency of illness and improved appetite, and better growth among most
of the participants. One of the participants in a separate study, Stella, a
27-year-old woman with AIDS, was given our product. Within six months,
Re-Vita's Liqua Health has made the AIDS virus non-detectable. This news is
so exciting. We know we have a great product and now we have the medical
testing and evidence to back it up.

In Kenya, Re-Vita's Liqua
Health is being
distributed to participants in the KEMRI
Research Institute study.

H.E. Dr. Kenneth Kuanda, Former
President of Zambia with (L-R) Dr. John Mallaris -
Re-Vita Representative, Bob Weatherly -
President/Founder of Re-Vita, Dr. Davy Keoch, Dr. Phoebe Josiah, Mr.
Dunstan Ngumo - Deputy Director in KEMRI Boardroom.

H.E. Dr. Kenneth Kuanda, is shown
in laboratory facilities at the Centre for Traditional Medicines and
Drugs Research, KEMRI, along with Dr. John Malliris of Re-Vita and Dr.
Kofi Tsekpo, Assistant Director of Communications at KEMRI.
|
|
Conclusions of the Study on Effect
of Multiple Micronutrients and
Amino Acids Formulation
[Liqua Health®] on
Nutrition and Health of
Undernourished Pre-School Age Children
The findings for the
first 28 weeks attributed to reduction of pooled anemia and moderate to
severe anemia by Liqua Health were 93.6% and 76.3% respectively.*
Anaemia control and Hb changes
●
LH supplementation with servings equivalent to
WHO/UNICEF/INACG recommendations for 8 weeks and at >51% compliance
halved the prevalence of moderate to severe anaemia in children at high
risk of malaria and protein-calorie malnutrition.
●
LH supplementation of children with chronic
anaemia due to multiple causes reduced the prevalence of moderate to
severe grades of anaemia by 27.9% during high pressure malaria
transmission season. This underlined the need to combine supplementation
and anti-malarial intervention during high transmission periods.
●
The risk of severe forms of anaemia decreased with
increasing compliance to LH supplementation during low malaria
transmission season.
●
Reversal of Hb and age relationship from negative
to weakly positive association after 28 weeks of LH supplementation to
children with chronic anaemia confirmed the need for longer periods of
supplementation to restore normal erythropoiesis as suggested in
WHO/UNICEF/INACG guidelines. The need to bring forward the starting age
for supplementation from 6 months to 4 months is also indicated.
Vitamin A
Deficiency (VAD) control
●
LH supplementation for 28 weeks reduced the
prevalence of VAD by >48% and low liver stores by >45%. This underlined
high bio-conversion of Spirulina ß-carotene
to Vitamin A in the LH formulation.
●
There was no demonstrable hypervitaminosis A after
LH supplementation for 28 weeks with or without a single large dose
Vitamin A. This conformed with physiologically regulated bio-conversion
of ß-carotene to meet body needs
thereby eliminating risk of overloads.
Physical growth
●
Despite persistant food insecurity, LH
supplementation, especially in combination with Vit A showed potential
in reversing stunting. Grossly sub-optional protein and calorie intake
among subjects possibly precluded definitive conclusion of the
hypothesis that LH supplementation accelerates reversal of stunting,
underweight and wasting among vulnerable children with basic minimum
energy and protein intake.
*The reduction with the
result of a field worker that did not follow procedures.
|
|
|